Article
Desloratadine Rescues Schizophrenia-like Phenotypes by Inhibiting the Pathogenic 5-HT2AR-PI3K/AKT/mTOR Signaling Axis.
Molecular neurobiology - 24 Jun 2026
Yao Yuhan, Zhao Weiliang, Chen Junyang, Wang Shentong, Song Zhiyao, Sun Lin, Hu Yubo, Li Longyun
Abstract excerpt
The 5-HT2A receptor (5-HT2AR) is a validated target in schizophrenia (SCZ); however, the therapeutic potential of repurposed drugs targeting this pathway remains underexplored. Here, we show that the antihistamine desloratadine (DLT) robustly ameliorates a full spectrum of SCZ-like behavioral deficits in an MK-801-induced male mouse model. Single-nucleus RNA sequencing (snRNA-seq) analysis revealed 5-HT2AR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
